Henry Schein Intrinsic Value Calculator – HENRY SCHEIN Reports Earnings Results for Second Quarter of FY2023 Ending August 7, 2023

August 15, 2023

🌥️Earnings Overview

HENRY SCHEIN ($NASDAQ:HSIC) announced its second-quarter earnings results for the fiscal year ending August 7 2023, on June 30 2023. Their total revenue was USD 3100.0 million, a 2.3% rise from the same period in FY2022. Despite this, their net income dropped 12.5% year on year to USD 140.0 million.

Stock Price

On Monday, HENRY SCHEIN reported its earnings results for the second quarter of FY2023 ending August 7, 2023. Despite expectations of a successful quarter, the company’s stock opened at $79.2 and eventually closed at $75.9 – a decrease of 2.8% from its previous closing price of 78.1. This dip in stock prices can be attributed to HENRY SCHEIN’s weaker than expected earnings results.

HENRY SCHEIN’s disappointing earnings results caused a considerable drop in their stock price, leaving investors to worry about the future performance of the company. Nevertheless, HENRY SCHEIN remains confident in their ability to bounce back in future quarters and have set out to achieve new strategies to drive growth and improve their financial performance. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Henry Schein. More…

    Total Revenues Net Income Net Margin
    12.6k 458 4.7%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Henry Schein. More…

    Operations Investing Financing
    653 -557 -61
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Henry Schein. More…

    Total Assets Total Liabilities Book Value Per Share
    9.15k 4.14k 27.26
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Henry Schein are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    10.7% 13.8% 5.4%
    FCF Margin ROE ROA
    4.2% 12.1% 4.6%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Henry Schein Intrinsic Value Calculator

    At GoodWhale, we have been analyzing HENRY SCHEIN‘s fundamentals in detail to estimate its intrinsic value. We have concluded that the intrinsic value of HENRY SCHEIN share comes out to be around $83.6 thanks to our proprietary Valuation Line. This means that investing in HENRY SCHEIN stock right now would still be a profitable venture. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis

  • Peers

    Henry Schein Inc is one of the largest companies in the dental supplies industry.

    However, it faces stiff competition from Healthlead PCL, Patterson Companies Inc, and Alfresa Holdings Corp. All four companies are large, international players in the dental supplies industry.

    – Healthlead PCL ($SET:HL)

    LeadPCL is a Thailand-based company engaged in the manufacture and sale of lead products. The Company offers lead ingots, lead sheets, lead pipes, lead wires, lead oxides and other lead products. It also provides lead recycling services. The Company’s products are used in a range of applications, including in the automotive, electronics, construction and medical industries.

    – Patterson Companies Inc ($NASDAQ:PDCO)

    Patterson Companies Inc is a leading provider of animal health and dental products and services. The company has a market cap of 2.61B as of 2022 and a return on equity of 16.53%. Patterson Companies Inc operates in the United States, Canada, and Europe. The company’s products and services include veterinary supplies, dental supplies, and diagnostic imaging. Patterson Companies Inc is headquartered in Minneapolis, Minnesota.

    – Alfresa Holdings Corp ($TSE:2784)

    Alfresa Holdings Corp is a Japanese pharmaceutical and medical equipment company with a market cap of 280.99B as of 2022. The company has a Return on Equity of 6.23%. Alfresa Holdings Corp is engaged in the research, development, manufacture, and sale of pharmaceuticals and medical equipment. The company’s products include drugs for the treatment of cancer, infectious diseases, and cardiovascular diseases; and medical devices for use in surgery, diagnosis, and treatment.


    Henry Schein‘s second quarter earnings results for FY2023 showed total revenue of USD 3100.0 million, a 2.3% increase from the prior year period. Net income decreased 12.5% to USD 140.0 million. Investors should consider the impact of this decrease in net income when making long-term investments in Henry Schein. Although the company’s total revenue increased, the lower net income could be indicative of an underlying issue in the company’s operations.

    Additionally, investors should keep an eye on future earnings reports to see if the net income trend continues in upcoming quarters.

    Recent Posts

    Leave a Comment